Lipid metabolite levels recovered from BAL fluid correlate with lung function of COPD patients and controls

E. Csanky, R. Ruhl, A. Vako, L. Takacs, W. Hempel (Debrecen, Hungary; Evry, France)

Source: Annual Congress 2008 - Novel trends in functional genomics and molecular pathology of neoplastic and non-neoplastic lung diseases
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
E. Csanky, R. Ruhl, A. Vako, L. Takacs, W. Hempel (Debrecen, Hungary; Evry, France). Lipid metabolite levels recovered from BAL fluid correlate with lung function of COPD patients and controls. Eur Respir J 2008; 32: Suppl. 52, 404

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Increased activin-a expression in serum, BAL and bronchial tissue of asthmatic patients
Source: Annual Congress 2009 - Novel approaches in asthma
Year: 2009


Stress protein expression in lung fibroblasts and BAL cells in COPD patients and healthy subjects.
Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies
Year: 2020


Determination of IL-8 concentration and the activity of β-glucuronidase in BAL samples in children with inflammatory lung disease
Source: Annual Congress 2010 - From viral bronchiolitis to recurrent pneumonia in childhood: diagnosis, treatment and underlying factors
Year: 2010


The influence of the COPD exacerbation treatment on the MMP-9 concentration in serum, induced sputum and BAL
Source: Eur Respir J 2005; 26: Suppl. 49, 298s
Year: 2005

CCL20 level in bronchoalveolar lavage fluid is correlated with the levels of serum indications in patients with pulmonary sarcoidosis
Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease
Year: 2010


Increased serum α1-antitrypsin level in COPD patients with predominant lung emphysema
Source: Eur Respir J 2001; 18: Suppl. 33, 248s
Year: 2001

Plasma markers of oxidative protein damage do not correlate with lung function or COPD in smokers
Source: Eur Respir J 2006; 28: Suppl. 50, 144s
Year: 2006

Increased levels of osteopontin in sputum supernatant in patients with COPD
Source: Annual Congress 2012 - Airway diseases: from invasive to noninvasive biomarkers
Year: 2012


Cytokine and protein profile in BAL from patients with sarcoidosis and IPF
Source: Eur Respir J 2001; 18: Suppl. 33, 195s
Year: 2001

Increased levels of hyaluronan in induced sputum from COPD patients
Source: Eur Respir J 2003; 22: Suppl. 45, 436s
Year: 2003

Correlation between cellularity of bronchoalveolar lavage (BAL) and parameters of lung function (LF) in patients with sarcoidosis
Source: Eur Respir J 2003; 22: Suppl. 45, 180s
Year: 2003

Microparticles-associated tissue factor activity is increased in bronchoalveolar lavage of patients with pulmonary fibrosis and correlates with functional impairment
Source: Annual Congress 2011 - The ageing pulmonary interstitium
Year: 2011

Studies on interferon-gamma (IFN-γ) expression in lower airways of patients with idiopathic pulmonary fibrosis (IPF), sarcoidosis and pneumoconioses. Lower IFN-γ levels in bronchoalveolar lavage (BAL) supernatants of IPF subgroup with decrease
Source: Eur Respir J 2007; 30: Suppl. 51, 121s
Year: 2007

Osteopontin expression is increased in serum, BAL and bronchial tissue of asymptomatic smokers
Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic
Year: 2009


Exosomes are differentially present in bronchoalveolar lavage (BAL) of smokers and patients with COPD and IPF
Source: International Congress 2019 – Novel mechanisms elucidated by translational studies of COPD
Year: 2019

Alterations in sputum inflammatory markers during exacerbations for COPD patients with different stable state levels
Source: International Congress 2019 – Host-microbe interactions in lung disease and exacerbations
Year: 2019


High levels of pepsin A in bronchoalveolar lavage fluid of patients with exacerbation of interstitial lung diseases and no evidence of infection
Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease
Year: 2010

Interleurin-4 and immunoglobulin E levels in bronchoalveolar lavage fluid and blood serum in patients with bronchial asthma and lung tuberculosis
Source: Eur Respir J 2001; 18: Suppl. 33, 271s
Year: 2001

Determination of a typical protein expression profile in bronchoalveolar lavage fluid (BALF) in patients with idiopathic pulmonary fibrosis-usual interstitial pneumonia (IPF-UIP) using SELDI-mass spectrometry
Source: Annual Congress 2007 - Pathogenesis of idiopathic interstitial pneumonia including idiopathic pulmonary fibrosis
Year: 2007


Haemoxygenase-1 expression in broncho-alveolar lavage fluid alveolar macrophages is diminished in patients with COPD
Source: Eur Respir J 2002; 20: Suppl. 38, 404s
Year: 2002